ArticleFrontiers in pharmacology2022

Identification of WT161 as a Potent Agent for the Treatment of Colitis by Targeting the Nucleotide-Binding Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome.

Xiuyan Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.